Arthritis’ Affect on the United States Population

A recent report published by the CDC indicates that approximately one quarter (52.5 million) of all U.S. citizens suffer from at least one form of arthritis, with osteoarthritis being the most common. According to the data, the disease itself hinders the mobility of 10% of all adults, which is a dramatic number considering the potential for lost productivity both in the workforce, and at home.

man massaging hands

Researchers posit that by the year 2030 the disease will affect an estimated 57 million Americans. While this estimate is fairly accurate, what researchers didn’t correctly foresee was the current number of individuals with hindered mobility. Past estimates projected 20 million people to suffer from mobility impairment by the year 2020. The figure is currently at 22.7 million, making it far ahead of initial estimates.

One theory attributes these numbers to the rapid spike in obesity seen during the last decade. According to the CDC, more than one-third of Americans are obese. Obesity is a huge contributor to the onset and development of osteoarthritis. The situation can be quite volatile, as both conditions exacerbate one another. OA hinders mobility and exercise, which in turn promotes weight gain, and vice versa.

Arthritis can affect one’s productivity both at home, and at work. Such personal financial losses contribute to a patient’s deficit, which is already in motion because of the healthcare costs attributed to treating the condition in the first place. As you can see, the situation becomes somewhat of a vicious cycle. Prevention and treatment are crucial if one wishes to maintain mobility, and when facing these issues later on, a generally improved quality of day-to-day living.

Here at Flexcin we strive to improve the lifestyles of our customers through health education. Visit our blog for further information on diet, exercise, and pain relief to help ensure you continue to live a healthy, happy life.

Flexcin

Flexcin International has been helping people with joint pain since 2000 by making high quality joint supplements based on the ingredient Cetyl Myristoleate (CM8), which holds multiple patents for the treatment of arthritis.You can find more info about Flexcin here, or see our products here.
Flexcin

Leave a Reply

Your email address will not be published. Required fields are marked *